Equities

Indraprastha Medical Corporation Ltd

INDRAMEDCO:NSI

Indraprastha Medical Corporation Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)246.32
  • Today's Change-3.99 / -1.59%
  • Shares traded282.33k
  • 1 Year change+173.69%
  • Beta0.8010
Data delayed at least 15 minutes, as of Jun 14 2024 11:29 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. The Company provides various services, such as in-patients, out-patients and clinical services. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. Indraprastha Apollo Hospitals has various specialties, such as anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics and gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, ophthalmology, plastic and reconstructive surgery, respiratory and sleep medicine, rheumatology, spine surgery, urology and andrology.

  • Revenue in INR (TTM)12.45bn
  • Net income in INR1.24bn
  • Incorporated1988
  • Employees2.95k
  • Location
    Indraprastha Medical Corporation LtdSarita Vihar,, Delhi-Mathura RoadNEW DELHI 110076IndiaIND
  • Phone+91 1 129872126
  • Fax+91 1 126825601
  • Websitehttps://delhi.apollohospitals.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
GPT Healthcare Ltd3.04bn377.89m12.66bn1.90k32.705.8022.714.174.724.7237.9726.630.90447.3612.82--11.2410.1814.7312.9779.3277.9912.4310.330.932610.810.122712.7810.8518.4222.4626.15-5.19--
Max India Ltd1.76bn-563.80m12.85bn19.00--2.61--7.32-13.08-13.0840.74114.050.24432.0345.05---7.87---9.95--66.9165.15-32.22-24.362.43-18.420.0813---12.642.82-443.01------
Krsnaa Diagnostics Ltd6.20bn568.40m21.52bn2.56k38.252.6616.383.4717.4217.42190.03250.790.59534.634.97--5.466.726.688.5977.2482.559.1711.741.374.230.1648--27.2024.25-8.49--14.21--
Indraprastha Medical Corporation Ltd12.45bn1.24bn22.58bn2.95k18.224.7313.771.8113.5213.52135.7652.121.9566.2219.66--19.3912.7425.2117.0457.4957.379.966.731.8237.750.066429.1313.299.5743.8934.2632.3422.98
Artemis Medicare Services Ltd8.79bn491.41m24.62bn1.94k50.795.4927.522.803.543.5463.0232.750.93640.009.20--5.24--6.66------5.594.590.92082.950.4133--19.149.9627.3219.12----
Shalby Ltd9.34bn840.80m30.60bn2.68k36.703.0622.543.287.787.7886.2193.330.64642.407.44--5.784.827.065.5345.9063.928.948.200.98087.780.272719.1216.0115.1024.1921.578.3919.14
Thyrocare Technologies Ltd5.72bn707.70m34.59bn1.65k48.716.5629.686.0513.4113.41108.0899.520.89594.438.89--10.8918.1712.5520.9770.8569.8112.1519.562.5526.830.074383.568.587.269.94-3.638.88-2.09
Yatharth Hospital & Trauma Cre Srvcs Ltd6.70bn1.14bn36.64bn--27.734.1925.485.4715.3915.3991.17101.84----------11.27--13.7380.1478.5017.0812.307.4741.510.0883--28.8845.7874.0695.813.69--
Healthcare Global Enterprises Ltd19.08bn481.40m54.50bn5.50k114.076.6025.272.863.433.43136.1259.290.759621.966.40--1.65-2.262.26-3.0553.4053.782.17-3.500.85681.390.5956--12.8014.3564.03--0.0453--
Data as of Jun 14 2024. Currency figures normalised to Indraprastha Medical Corporation Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

2.81%Per cent of shares held by top holders
HolderShares% Held
quant Money Managers Ltd.as of 31 May 20242.40m2.61%
Acadian Asset Management LLCas of 31 Mar 2024107.45k0.12%
American Century Investment Management, Inc.as of 06 Jun 202423.20k0.03%
Fidelity Management & Research Co. LLCas of 30 Apr 202422.41k0.02%
Lazard Asset Management LLCas of 31 May 202415.05k0.02%
Dimensional Fund Advisors LPas of 06 Jun 202410.39k0.01%
Motilal Oswal Asset Management Co. Ltd.as of 31 May 2024549.000.00%
DFA Australia Ltd.as of 30 Apr 2024233.000.00%
More ▼
Data from 31 Mar 2024 - 31 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.